Q fever: The neglected biothreat agent

Journal of Medical Microbiology

Volumn 60, Issue 1, 2011, Pages 9-21

  Oyston, P C F ^a   Davies, C ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; BACTERIAL VECTOR; CHLORAMPHENICOL; CHLOROFORM METHANOL EXTRACT; CHLOROQUINE; COTRIMOXAZOLE; DISINFECTANT AGENT; DOXYCYCLINE; FORMALIN INACTIVATED CULTURE EXTRACT; HYPOCHLORITE; LIVE VACCINE; OFLOXACIN; Q VAX; SUBUNIT VACCINE; TRICHLOROACETIC ACID EXTRACT; UNCLASSIFIED DRUG;

ANTIBIOTIC THERAPY; BACTERIAL GROWTH; BACTERIOLOGY; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; CELLULAR IMMUNITY; CHEMICAL STRESS; CHRONIC FATIGUE SYNDROME; COXIELLA BURNETII; DEATH; DESICCATION; ECOLOGY; ENDOCARDITIS; EPIDEMIC; ERYTHEMA; FEVER; FLU LIKE SYNDROME; GEOGRAPHICAL VARIATION (SPECIES); HEADACHE; HEPATITIS; HIGH TEMPERATURE; HUMAN; HUMORAL IMMUNITY; IMMUNOGENICITY; INFECTION CONTROL; NONHUMAN; OSMOTIC STRESS; PARASITE VECTOR; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; Q FEVER; REVIEW; SIDE EFFECT; SWELLING; TAXONOMY; ULTRAVIOLET RADIATION;

BACTERIOLOGICAL TECHNIQUES; BIOLOGICAL WARFARE AGENTS; BIOTERRORISM; COXIELLA BURNETII; EUROPE; GENETICS, MICROBIAL; HUMANS; Q FEVER; VIRULENCE;

EID: 78650837632     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.024778-0     Document Type: Review

References (156)

1. Ackland, J. R., Worswick, D. A. & Marmion, B. P. (1994). Vaccine prophylaxis of Q fever - a follow-up study of the efficacy of Q-Vax (CSL) 1985-1990. Med J Aust 160, 704-708.
2. Aguilera, M., Salinas, R., Rosales, E., Carminati, S., Colombo, M. I. & Berón, W. (2009). Actin dynamics and Rho GTPases regulate the size and formation of parasitophorous vacuoles containing Coxiella burnetii. Infect Immun 77, 4609-4620.
3. Akporiaye, E. T. & Baca, O. G. (1983). Superoxide anion production and superoxide dismutase and catalase activities in Coxiella burnetii. J Bacteriol 154, 520-523.
4. Angelakis, E. & Raoult, D. (2010). Q fever. Vet Microbiol 140, 297-309.
5. Ascher, M. S., Berman, M. A. & Ruppanner, R. (1983). Initial clinical and immunological evaluation of a new phase I Q fever vaccine and skin test in humans. J Infect Dis 148, 214-222.
6. Astobiza, I., Barandika, J. F., Hurtado, A., Juste, R. A. & Garcia-Perez, A. L. (2010). Kinetics of Coxiella burnetii excretion in a commercial dairy sheep flock after treatment with oxytetracycline. Vet J 184, 172-175.
7. d) mice infected with the Nine Mile isolate of Coxiella burnetii. J Infect Dis 170, 223-226.
8. Ayres, J. G., Smith, E. G. & Flint, N. (1996). Protracted fatigue and debility after acute Q fever. Lancet 347, 978-979.
9. Ayres, J. G., Flint, N., Smith, E. G., Tunnicliffe, W. S., Fletcher, T. J., Hammond, K., Ward, D. & Marmion, B. P. (1998). Post-infection fatigue syndrome following Q fever. QJM 91, 105-123.
10. Babudieri, B. (1959). Q fever: a zoonosis. Adv Vet Sci 5, 81-154.
11. Baca, O. G. & Paretsky, D. (1983). Q fever and Coxiella burnetii: a model for host-parasite interactions. Microbiol Rev 47, 127-149.
12. Baca, O. G., Klassen, D. A. & Aragon, A. S. (1993). Entry of Coxiella burnetii into host cells. Acta Virol 37, 143-155.
13. Beare, P. A., Howe, D., Cockrell, D. C., Omsland, A., Hansen, B. & Heinzen, R. A. (2009a). Characterization of a Coxiella burnetii ftsZ mutant generated by Himar1 transposon mutagenesis. J Bacteriol 191, 1369-1381.
14. Beare, P. A., Unsworth, N., Andoh, M., Voth, D. E., Omsland, A., Gilk, S. D., Williams, K. P., Sobral, B. W., Kupko, J. J., III & other authors (2009b). Comparative genomics reveal extensive transposon-mediated genomic plasticity and diversity among potential effector proteins within the genus Coxiella. Infect Immun 77, 642-656.
15. Bell, J. F., Lackman, D. B., Meis, A. & Hadlow, W. J. (1964). Recurrent reaction at site of Q fever vaccination in a sensitized person. Mil Med 129, 591.
16. Berón, W., Gutierrez, M. G., Rabinovitch, M. & Colombo, M. I. (2002). Coxiella burnetii localizes in a Rab7-labeled compartment with autophagic characteristics. Infect Immun 70, 5816-5821.
17. Burnet, F. M. & Freeman, M. (1937). Experimental studies on the virus of Q fever. Med J Aust 2, 299-302.
18. Burnet, F. M. & Freeman, M. (1983). Experimental studies on the virus of "Q" fever (reprinted). Rev Infect Dis 5, 800-808.
19. Capo, C., Zugun, F., Stein, A., Tardei, G., Lepidi, H., Raoult, D. & Mege, J. L. (1996). Upregulation of tumor necrosis factor alpha and interleukin-1 beta in Q fever endocarditis. Infect Immun 64, 1638-1642.
20. Capo, C., Moynault, A., Collette, Y., Olive, D., Brown, E. J., Raoult, D. & Mege, J. L. (2003). Coxiella burnetii avoids macrophage phagocytosis by interfering with spatial distribution of complement receptor 3. J Immunol 170, 4217-4225.
21. Casadevall, A. & Pirofski, L. A. (2006). A reappraisal of humoral immunity based on mechanisms of antibody-mediated protection against intracellular pathogens. Adv Immunol 91, 1-44. (Pubitemid 44286993)
22. Chen, S. Y., Vodkin, M., Thompson, H. A. & Williams, J. C. (1990). Isolated Coxiella burnetii synthesizes DNA during acid activation in the absence of host cells. J Gen Microbiol 136, 89-96. (Pubitemid 20045974)
23. Cockrell, D. C., Beare, P. A., Fischer, E. R., Howe, D. & Heinzen, R. A. (2008). A method for purifying obligate intracellular Coxiella burnetii that employs digitonin lysis of host cells. J Microbiol Methods 72, 321-325.
24. Coleman, S. A., Fischer, E. R., Howe, D., Mead, D. J. & Heinzen, R. A. (2004). Temporal analysis of Coxiella burnetii morphological differentiation. J Bacteriol 186, 7344-7352. (Pubitemid 39383119)
25. Cox, H. R. & Bell, E. J. (1939). The cultivation of Rickettsia diaporica in tissue culture and in the tissues of developing chick embryos. Public Health Rep 54, 2171-2178.
26. Davis, G. E. & Cox, H. R. (1938). A filter-passing infectious agent isolated from ticks. I. Isolation from Dermacentor andersoni, reactions in animals, and filtration experiments. Public Health Rep 53, 2259-2282.
27. Davis, J. L. & Patrick, W. C. (1965). New method for purifying Coxiella burnetii by dextran sulfate precipitation followed by centrifugation. Appl Microbiol 13, 99.
28. Dellacasagrande, J., Capo, C., Raoult, D. & Mege, J. L. (1999). IFN-γ-mediated control of Coxiella burnetii survival in monocytes: the role of cell apoptosis and TNF. J Immunol 162, 2259-2265. (Pubitemid 29288849)
29. Denison, A. M., Massung, R. F. & Thompson, H. A. (2007). Analysis of the O-antigen biosynthesis regions of phase II Isolates of Coxiella burnetii. FEMS Microbiol Lett 267, 102-107.
30. Derrick, E. H. (1937). "Q" fever, a new fever entity: clinical features, diagnosis and laboratory investigation. Med J Aust 2, 281-299.
31. Dupuis, G., Petite, J., Peter, O. & Vouilloz, M. (1987). An important outbreak of human Q fever in a Swiss alpine valley. Int J Epidemiol 16, 282-287. (Pubitemid 17108848)
32. Enserink, M. (2010). Questions abound in Q-fever explosion in the Netherlands. Science 327, 266-267.
33. Felsheim, R. F., Herron, M. J., Nelson, C. M., Burkhardt, N. Y., Barbet, A. F., Kurtti, T. J. & Munderloh, U. G. (2006). Transformation of Anaplasma phagocytophilum. BMC Biotechnol 6, 42.
34. Fenollar, F. & Raoult, D. (2007). Molecular diagnosis of bloodstream infections caused by non-cultivable bacteria. Int J Antimicrob Agents 30, S7-S15. (Pubitemid 47505302)
35. Fenollar, F., Fournier, P. E. & Raoult, D. (2004). Molecular detection of Coxiella burnetti in the sera of patients with Q fever endocarditis or vascular infection. J Clin Microbiol 42, 4919-4924.
36. Fernández-Guerrero, M. L., Muelas, J. M., Aguado, J. M., Renedo, G., Fraile, J., Soriano, F. & De Villalobos, E. (1988). Q fever endocarditis on porcine bioprosthetic valves. Clinicopathologic features and microbiologic findings in 3 patients treated with doxycycline, cotrimoxazole, and valve-replacement. Ann Intern Med 108, 209-213.
37. Fiset, P. (1957). Phase variation of Rickettsia (Coxiella) burnetii; study of the antibody response in guinea pigs and rabbits. Can J Microbiol 3, 435-445.
38. Fishbein, D. B. & Raoult, D. (1992). A cluster of Coxiella burnetii infections associated with exposure to vaccinated goats and their unpasteurized dairy products. Am J Trop Med Hyg 47, 35-40.
39. Fitzpatrick, K. A., Kersh, G. J. & Massung, R. F. (2010). Practical method for extraction of PCR-quality DNA from environmental soil samples. Appl Environ Microbiol 76, 4571-4573.
40. Franco, I. S., Shuman, H. A. & Charpentier, X. (2009). The perplexing functions and surprising origins of Legionella pneumophila type IV secretion effectors. Cell Microbiol 11, 1435-1443.
41. Freylikhman, O., Tokarevich, N., Suvorov, A., Vorobiova, E. & Totolian, A. (2003). Coxiella burnetti persistence in three generations of mice after application of live attenuated human M-44 vaccine against Q fever. Ann N Y Acad Sci 990, 496-499.
42. Fries, L. F., Waag, D. M. & Williams, J. C. (1993). Safety and immunogenicity in human volunteers of a chloroform-methanol residue vaccine for Q fever. Infect Immun 61, 1251-1258.
43. Gami, A. S., Antonios, V. S., Thompson, R. L., Chaliki, H. P. & Ammash, N. M. (2004). Q fever endocarditis in the United States. Mayo Clin Proc 79, 253-257.
44. Gimenez, D. F. (1964). Staining rickettsiae in yolk-sac cultures. Stain Technol 39, 135-140.
45. Gonder, J. C., Kishimoto, R. A., Kastello, M. D., Pedersen, C. E. & Larson, E. W. (1979). Cynomolgus monkey model for experimental Q fever infection. J Infect Dis 139, 191-196.
46. Gutierrez, M. G., Vázquez, C. L., Munafo, D. B., Zoppino, F. C. M., Berón, W., Rabinovitch, M. & Colombo, M. I. (2005). Autophagy induction favours the generation and maturation of the Coxiella-replicative vacuoles. Cell Microbiol 7, 981-993.
47. Hacker, J. & Fischer, G. (1993). Immunophilins: structure-function relationship and possible role in microbial pathogenicity. Mol Microbiol 10, 445-456.
48. Hackstadt, T. (1990). The role of lipopolysaccharides in the virulence of Coxiella burnetii. Ann N Y Acad Sci 590, 27-32.
49. Hackstadt, T. & Williams, J. C. (1981). Biochemical stratagem for obligate parasitism of eukaryotic cells by Coxiella burnetii. Proc Natl Acad Sci U S A 78, 3240-3244.
50. Hackstadt, T. & Williams, J. C. (1983). pH-dependence of the Coxiella burnetii glutamate transport system. J Bacteriol 154, 598-603.
51. Hackstadt, T., Peacock, M. G., Hitchcock, P. J. & Cole, R. L. (1985). Lipopolysaccharide variation in Coxiella burnetii: intrastrain heterogeneity in structure and antigenicity. Infect Immun 48, 359-365.
52. Heinzen, R. A., Scidmore, M. A., Rockey, D. D. & Hackstadt, T. (1996). Differential interaction with endocytic and exocytic pathways distinguish parasitophorous vacuoles of Coxiella burnetii and Chlamydia trachomatis. Infect Immun 64, 796-809.
53. Heinzen, R. A., Hackstadt, T. & Samuel, J. E. (1999). Developmental biology of Coxiella burnetii. Trends Microbiol 7, 149-154.
54. Hendrix, L. & Mallavia, L. P. (1984). Active transport of proline by Coxiella burnetii. J Gen Microbiol 130, 2857-2863.
55. Hilbink, F., Penrose, M., Kovácová, E. & Kazár, J. (1993). Q fever is absent from New Zealand. Int J Epidemiol 22, 945-949.
56. Honstettre, A., Ghigo, E., Moynault, A., Capo, C., Toman, R., Akira, S., Takeuchi, O., Lepidi, H., Raoult, D. & Mege, J. L. (2004). Lipopolysaccharide from Coxiella burnetii is involved in bacterial phagocytosis, filamentous actin reorganization, and inflammatory responses through Toll-like receptor 4. J Immunol 172, 3695-3703.
57. Hoover, T. A., Culp, D. W., Vodkin, M. H., Williams, J. C. & Thompson, H. A. (2002). Chromosomal DNA deletions explain phenotypic characteristics of two antigenic variants, phase II and RSA 514 (Crazy), of the Coxiella burnetii Nine Mile strain. Infect Immun 70, 6726-6733.
58. Howe, D. & Mallavia, L. P. (2000). Coxiella burnetti exhibits morphological change and delays phagolysosomal fusion after internalization by J774A.1 cells. Infect Immun 68, 3815-3821.
59. Howe, D., Shannon, J. G., Winfree, S., Dorward, D. W. & Heinzen, R. A. (2010). Coxiella burnetii phase I and II variants replicate with similar kinetics in degradative phagolysosome-like compartments of human macrophages. Infect Immun 78, 3465-3474.
60. Izzo, A. A., Marmion, B. P. & Worswick, D. A. (1988). Markers of cell-mediated immunity after vaccination with an inactivated, whole-cell Q fever vaccine. J Infect Dis 157, 781-789.
61. Jäger, C., Lautenschläger, S., Willems, H. & Baljer, G. (2002). Coxiella burnetii plasmid types QpDG and QpH1 are closely related and likely identical. Vet Microbiol 89, 161-166.
62. Kazár, J. (1996). Q fever. In Rickettsiae and Rickettsial Diseases, pp. 353-362. Edited by J. Kazár & R. Toman. Bratislava: Slovak Academy of Sciences.
63. Kazár, J., Brezina, R., Palanová, A., Tvrdá, B. & Schramek, S. (1982). Immunogenicity and reactogenicity of a Q fever chemovaccine in persons professionally exposed to Q fever in Czechoslovakia. Bull World Health Organ 60, 389-394.
64. Kazár, J., Schramek, S., Lisák, V. & Brezina, R. (1987). Antigenicity of chloroform-methanol-treated Coxiella burnetii preparations. Acta Virol 31, 158-167.
65. Kersh, G. J., Wolfe, T. M., Fitzpatrick, K. A., Candee, A. J., Oliver, L. D., Patterson, N. E., Self, J. S., Priestley, R. A., Loftis, A. D. & Massung, R. F. (2010). Presence of Coxiella burnetii DNA in the environment of the United States, 2006 to 2008. Appl Environ Microbiol 76, 4469-4475.
66. Kishimoto, R. A., Rozmiarek, H. & Larson, E. W. (1978). Experimental Q fever infection in congenitally athymic nude mice. Infect Immun 22, 69-71.
67. Klee, S. R., Ellerbrok, H., Tyczka, J., Franz, T. & Appel, B. (2006). Evaluation of a real-time PCR assay to detect Coxiella burnetii. Ann N Y Acad Sci 1078, 563-565.
68. Koster, F. T., Williams, J. C. & Goodwin, J. S. (1985a). Cellular immunity in Q fever - modulation of responsiveness by a suppressor T cell-monocyte circuit. J Immunol 135, 1067-1072.
69. Koster, F. T., Williams, J. C. & Goodwin, J. S. (1985b). Cellular immunity in Q fever: specific lymphocyte unresponsiveness in Q fever endocarditis. J Infect Dis 152, 1283-1289.
70. Kovácová, E. & Kazár, J. (2002). Q fever - still a query and underestimated infectious disease. Acta Virol 46, 193-210.
71. Kristinsson, A. & Bentall, H. H. (1967). Medical and surgical treatment of Q-fever endocarditis. Lancet 290, 693-697.
72. La Scola, B., Lepidi, H. & Raoult, D. (1997). Pathologic changes during acute Q fever: influence of the route of infection and inoculum size in infected guinea pigs. Infect Immun 65, 2443-2447.
73. Lautenschläger, S., Willems, H., Jäger, C. & Baljer, G. (2000). Sequencing and characterization of the cryptic plasmid QpRS from Coxiella burnetii. Plasmid 44, 85-88.
74. Levy, P. Y., Drancourt, M., Etienne, J., Auvergnat, J. C., Beytout, J., Sainty, J. M., Goldstein, F. & Raoult, D. (1991). Comparison of different antibiotic regimens for therapy of 32 cases of Q fever endocarditis. Antimicrob Agents Chemother 35, 533-537.
75. Li, Q., Niu, D., Wen, B., Chen, M., Qiu, L. & Zhang, J. (2005). Protective immunity against Q fever induced with a recombinant P1 antigen fused with HspB of Coxiella burnetii. Ann N Y Acad Sci 1063, 130-142.
76. Liu, Z. M., Tucker, A. M., Driskell, L. O. & Wood, D. O. (2007). Mariner-based transposon mutagenesis of Rickettsia prowazekii. Appl Environ Microbiol 73, 6644-6649.
77. Lührmann, A. & Roy, C. R. (2007). Coxiella bumetii inhibits activation of host cell apoptosis through a mechanism that involves preventing cytochrome c release from mitochondria. Infect Immun 75, 5282-5289.
78. Madariaga, M. G., Rezai, K., Trenholme, G. M. & Weinstein, R. A. (2003). Q fever: a biological weapon in your backyard. Lancet Infect Dis 3, 709-721.
79. Mallavia, L. P. (1991). Genetics of Rickettsiae. Eur J Epidemiol 7, 213-221.
80. Marmion, B. P. (1967). Development of Q-fever vaccines, 1937 to 1967. Med J Aust 2, 1074-1078.
81. Marmion, B. P., Ormsbee, R. A., Kyrkou, M., Wright, J., Worswick, D. A., Izzo, A. A., Esterman, A., Feery, B. & Shapiro, R. A. (1990). Vaccine prophylaxis of abattoir-associated Q fever: 8 years' experience in Australian abattoirs. Epidemiol Infect 104, 275-287.
82. Marmion, B. P., Shannon, M., Maddocks, I., Storm, P. & Penttila, I. (1996). Protracted debility and fatigue after acute Q fever. Lancet 347, 977-978.
83. Marmion, B. P., Sukocheva, O., Storm, P. A., Lockhart, M., Turra, M., Kok, T., Ayres, J., Routledge, H. & Graves, S. (2009). Q fever: persistence of antigenic non-viable cell residues of Coxiella burnetii in the host - implications for post Q fever infection fatigue syndrome and other chronic sequelae. QJM 102, 673-684.
84. Marrie, T. J., Van Buren, J., Fraser, J., Haldane, E. V., Faulkner, R. S., Williams, J. C. & Kwan, C. (1985). Seroepidemiology of Q fever among domestic animals in Nova Scotia. Am J Public Health 75, 763-766.
85. Marrie, T. J., Stein, A., Janigan, D. & Raoult, D. (1996). Route of infection determines the clinical manifestations of acute Q fever. J Infect Dis 173, 484-487.
86. Maurin, M. & Raoult, D. (1999). Q fever. Clin Microbiol Rev 12, 518-553.
87. McCaul, T. F. (1991). The developmental cycle of Coxiella burnetii. In Q Fever: The Biology of Coxiella burnetii, pp. 223-258. Edited by J. C. Williams & H. A. Thompson. Boca Raton, FL: CRC Press.
88. McCaul, T. F. & Williams, J. C. (1981). Developmental cycle of Coxiella burnetii: structure and morphogenesis of vegetative and sporogenic differentiations. J Bacteriol 147, 1063-1076.
89. McCaul, T. F., Williams, J. C. & Thompson, H. A. (1991). Electron microscopy of Coxiella burnetii in tissue culture. Induction of cell types as products of developmental cycle. Acta Virol 35, 545-556.
90. Mege, J. L., Maurin, M., Capo, C. & Raoult, D. (1997). Coxiella burnetii: the 'query' fever bacterium. A model of immune subversion by a strictly intracellular microorganism. FEMS Microbiol Rev 19, 209-217.
91. Meghari, S., Bechah, Y., Capo, C., Lepidi, H., Raoult, D., Murray, P. J. & Mege, J. L. (2008). Persistent Coxiella burnetii infection in mice overexpressing IL-10: an efficient model for chronic Q fever pathogenesis. PLoS Pathog 4, e23.
92. Miceli, M. H., Veryser, A. K., Anderson, A. D., Hofinger, D., Lee, S. A. & Tancik, C. (2010). A case of person-to-person transmission of Q fever from an active duty service to his spouse. Vector Borne Zoonotic Dis 10, 539-541.
93. Milazzo, A., Hall, R., Storm, P. A., Harris, R. J., Winslow, W. & Marmion, B. P. (2001). Sexually transmitted Q fever. Clin Infect Dis 33, 399-402.
94. Mitchell, A. E., Sivitz, L. B. & Black, R. E. (2007). Infectious diseases diagnosed in US troops who served in the Persian Gulf War, Operation Enduring Freedom, or Operation Iraqi Freedom. In Gulf War and Health, vol. 5, Infectious Diseases, pp. 61-94. Washington, DC: The National Academies Press.
95. Mo, Y. Y., Cianciotto, N. P. & Mallavia, L. P. (1995). Molecular cloning of a Coxiella burnetii gene encoding a macrophage infectivity potentiator (Mip) analog. Microbiology 141, 2861-2871.
96. Morgan, J. K., Luedtke, B. E. & Shaw, E. I. (2010). Coxiella burnetii type IVB secretion system region I genes are expressed early during the infection of host cells. FEMS Microbiol Lett 305, 177-183.
97. Ninio, S. & Roy, C. R. (2007). Effector proteins translocated by Legionella pneumophila: strength in numbers. Trends Microbiol 15, 372-380.
98. Olson, J. G., Jones, F. R. & Blair, P. J. (2006). Rickettsia spp. In Principles and Practice of Clinical Bacteriology, pp. 285-294. Edited by S. H. Gillespie & P. M. Hawkey. Chichester, UK: Wiley.
99. Omsland, A., Cockrell, D. C., Howe, D., Fischer, E. R., Virtaneva, K., Sturdevant, D. E., Porcella, S. F. & Heinzen, R. A. (2009). Host cell-free growth of the Q fever bacterium Coxiella burnetii. Proc Natl Acad Sci U S A 106, 4430-4434.
100. Ormsbee, R. A. (1962). A method of purifying Coxiella burnetii and other pathogenic rickettsiae. J Immunol 88, 100-108.
101. Ormsbee, R. A. & Marmion, B. P. (1990). Prevention of Coxiella burnetii infection: vaccines and guidelines for those at risk. In Q Fever, vol. 1, The Disease, pp. 225-248. Edited by T. J. Marrie. Boca Raton, FL: CRC Press.
102. Ormsbee, R. A., Bell, E. J., Tallent, G. & Lackman, D. B. (1964). Influence of phase on protective potency of Q fever vaccine. J Immunol 92, 404.
103. Palmer, N. C., Kierstead, M., Key, D. W., Williams, J. C., Peacock, M. G. & Vellend, H. (1983). Placentitis and abortion in goats and sheep in Ontario caused by Coxiella burnetii. Can Vet J 24, 60-61.
104. Parkhill, J., Wren, B. W., Thomson, N. R., Titball, R. W., Holden, M. T., Prentice, M. B., Sebaihia, M., James, K. D., Churcher, C. & other authors (2001). Genome sequence of Yersinia pestis, the causative agent of plague. Nature 413, 523-527.
105. Pittman, P. R., Norris, S. L., Coonan, K. M. & Mckee, K. T. (2005). An assessment of health status among medical research volunteers who served in the Project Whitecoat program at Fort Detrick, Maryland. Mil Med 170, 183-187.
106. Rady, M., Glavits, R. & Nagy, G. (1985). Isolation of Coxiella burnetii and diagnosis of the Q-fever associated abortion in cows and ewes in Hungary. Magyar Allatorvosok Lapja 40, 343-349.
107. Raoult, D. (1990). Host factors in the severity of Q fever. Ann N Y Acad Sci 590, 33-38.
108. Raoult, D. (2009). Reemergence of Q fever after 11 September 2001. Clin Infect Dis 48, 558-559.
109. Redd, T. & Thompson, H. A. (1995). Secretion of proteins by Coxiella burnetii. Microbiology 141, 363-369.
110. Romano, P. S., Gutierrez, M. G., Berón, W., Rabinovitch, M. & Colombo, M. I. (2007). The autophagic pathway is actively modulated by phase II Coxiella burnetii to efficiently replicate in the host cell. Cell Microbiol 9, 891-909.
111. Russell-Lodrigue, K. E., Zhang, G. Q., McMurray, D. N. & Samuel, J. E. (2006). Clinical and pathologic changes in a guinea pig aerosol challenge model of acute Q fever. Infect Immun 74, 6085-6091.
112. Samuel, J. E., Frazier, M. E., Kahn, M. L., Thomashow, L. S. & Mallavia, L. P. (1983). Isolation and characterization of a plasmid from phase I Coxiella burnetii. Infect Immun 41, 488-493.
113. Savinelli, E. A. & Mallavia, L. P. (1990). Comparison of Coxiella burnetii plasmids to homologous chromosomal sequences present in a plasmidless endocarditis-causing isolate. Ann N Y Acad Sci 590, 523-533.
114. Schneeberger, P. M., Hermans, M. H. A., van Hannen, E. J., Schellekens, J. J. A., Leenders, A. C. A. P. & Wever, P. C. (2010). Real-time PCR with serum samples is indispensable for early diagnosis of acute Q fever. Clin Vaccine Immunol 17, 286-290.
115. Schramek, S. & Mayer, H. (1982). Different sugar compositions of lipopolysaccharides isolated from phase I and pure phase II cells of Coxiella burnetii. Infect Immun 38, 53-57.
116. Scott, G. H. & Williams, J. C. (1990). Susceptibility of Coxiella burnetii to chemical disinfectants. Ann N Y Acad Sci 590, 291-296.
117. Scott, G. H., Williams, J. C. & Stephenson, E. H. (1987). Animal models in Q fever: pathological responses of inbred mice to phase I Coxiella burnetii. J Gen Microbiol 133, 691-700.
118. Seshadri, R., Paulsen, I. T., Eisen, J. A., Read, T. D., Nelson, K. E., Nelson, W. C., Ward, N. L., Tettelin, H., Davidsen, T. M. & other authors (2003). Complete genome sequence of the Q-fever pathogen Coxiella burnetii. Proc Natl Acad Sci U S A 100, 5455-5460.
119. Shannon, J. G. & Heinzen, R. A. (2009). Adaptive immunity to the obligate intracellular pathogen Coxiella burnetii. Immunol Res 43, 138-148.
120. Shannon, J. G., Howe, D. & Heinzen, R. A. (2005). Virulent Coxiella burnetii does not activate human dendritic cells: role of lipopoly-saccharide as a shielding molecule. Proc Natl Acad Sci U S A 102, 8722-8727. (Pubitemid 40862802)
121. Shannon, J. G., Cockrell, D. C., Takahashi, K., Stahl, G. L. & Heinzen, R. A. (2009). Antibody-mediated immunity to the obligate intracellular bacterial pathogen Coxiella burnetii is Fc receptor- and complement-independent. BMC Immunol 10, 26.
122. Sidwell, R. W., Gebhardt, L. P. & Thorpe, B. D. (1964a). Studies of latent Q fever infections. 2. Effects of multiple cortisone injections. Am J Hyg 79, 320.
123. Sidwell, R. W., Gebhardt, L. P. & Thorpe, B. D. (1964b). Studies of latent Q fever infections. I. Effects of whole body X-irradiation upon latently infected guinea pigs, white mice and deer mice. Am J Hyg 79, 113.
124. Smith, D. J. W. (1940). Studies on the epidemiology of Q fever. III. The transmission of Q fever by the tick Haemaphysalis humerosa. Aust J Exp Biol Med Sci 18, 103-106.
125. Smith, D. J. W. (1941). Studies on the epidemiology of Q fever. VIII. The transmission of Q fever by the tick Rhipicephalus sanguineus. Aust J Exp Biol Med Sci 19, 119-122.
126. Stein, A. & Raoult, D. (1999). Pigeon pneumonia in Provence: a birdborne Q fever outbreak. Clin Infect Dis 29, 617-620. (Pubitemid 29439963)
127. Stein, A., Lepidi, H., Mege, J. L., Marrie, T. J. & Raoult, D. (2000). Repeated pregnancies in BALB/c mice infected with Coxiella burnetii cause disseminated infection, resulting in stillbirth and endocarditis. J Infect Dis 181, 188-194. (Pubitemid 30049048)
128. Suhan, M., Chen, S. Y., Thompson, H. A., Hoover, T. A., Hill, A. & Williams, J. C. (1994). Cloning and characterization of an autonomous replication sequence from Coxiella burnetii. J Bacteriol 176, 5233-5243. (Pubitemid 24273508)
129. Tigertt, W. D., Benenson, A. S. & Gochenour, W. S. (1961). Airborne Q fever. Bacteriol Rev 25, 285.
130. Tissot Dupont, H., Raoult, D., Brouqui, P., Janbon, F., Peyramond, D., Weiller, P.-J., Chicheportiche, C., Nezeri, M. & Poirier, R. (1992). Epidemiologic features and clinical presentation of acute Q fever in hospitalized patients: 323 French cases. Am J Med 93, 427-434.
131. To, H., Htwe, K. K., Kako, N., Kim, H. J., Yamaguchi, T., Fukushi, H. & Hirai, K. (1998). Prevalence of Coxiella burnetii infection in dairy cattle with reproductive disorders. J Vet Med Sci 60, 859-861. (Pubitemid 128531210)
132. Tyczka, J., Eberling, S. & Balfer, G. (2005). Immunization experiments with recombinant Coxiella burnetii proteins in a murine infection model. Ann N Y Acad Sci 1063, 143-148.
133. Valková, D. & Kazár, J. (1995). A new plasmid (Qpdv) common to Coxiella burnetti isolates associated with acute and chronic Q fever. FEMS Microbiol Lett 125, 275-280.
134. Vázquez, C. L. & Colombo, M. I. (2010a). Beclin 1 modulates the antiapoptotic activity of Bcl-2: insights from a pathogen infection system. Autophagy 6, 177-178.
135. Vázquez, C. L. & Colombo, M. I. (2010b). Coxiella burnetii modulates Beclin 1 and Bcl-2, preventing host cell apoptosis to generate a persistent bacterial infection. Cell Death Differ 17, 421-438.
136. Vogel, J. P. (2004). Turning a tiger into a house cat: using Legionella pneumophila to study Coxiella burnetii. Trends Microbiol 12, 103-105.
137. Vogel, J. P. & Isberg, R. R. (1999). Cell biology of Legionella pneumophila. Curr Opin Microbiol 2, 30-34.
138. Voth, D. E. & Heinzen, R. A. (2007). Lounging in a lysosome: the intracellular lifestyle of Coxiella burnetii. Cell Microbiol 9, 829-840. (Pubitemid 46394895)
139. Voth, D. E. & Heinzen, R. A. (2009). Coxiella type IV secretion and cellular microbiology. Curr Opin Microbiol 12, 74-80.
140. Voth, D. E., Howe, D. & Heinzen, R. A. (2007). Coxiella burnetii inhibits apoptosis in human THP-1 cells and monkey primary alveolar macrophages. Infect Immun 75, 4263-4271. (Pubitemid 47378082)
141. Voth, D. E., Howe, D., Beare, P. A., Vogel, J. P., Unsworth, N., Samuel, J. E. & Heinzen, R. A. (2009). The Coxiella burnetii ankyrin repeat domain-containing protein family is heterogeneous, with C-terminal truncations that influence Dot/Icm-mediated secretion. J Bacteriol 191, 4232-4242.
142. Waag, D. M. (2007). Coxiella burnetii: host and bacterial responses to infection. Vaccine 25, 7288-7295. (Pubitemid 47484005)
143. Waag, D. M., Byrne, W. R., Estep, J., Gibbs, P., Pitt, M. L. M. & Banfield, C. M. (1999). Evaluation of cynomolgus (Macaca fascicularis) and rhesus (Macaca mulatta) monkeys as experimental models of acute Q fever after aerosol exposure to phase I Coxiella burnetii. Lab Anim Sci 49, 634-638. (Pubitemid 30036297)
144. Waag, D. M., England, M. J., Tammariello, R. F., Byrne, W. R., Gibbs, P., Banfield, C. M. & Pitt, M. L. M. (2002). Comparative efficacy and immunogenicity of Q fever chloroform: methanol residue (CMR) and phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol. Vaccine 20, 2623-2634. (Pubitemid 34615605)
145. WHO (1970). Health Aspects of Chemical and Biological Weapons, 1st edn. Geneva: World Health Organization.
146. WHO (2004). Health Aspects of Chemical and Biological Weapons, 2nd edn. Geneva: World Health Organization.
147. Willems, H., Ritter, M., Jäger, C. & Thiele, D. (1997). Plasmidhomologous sequences in the chromosome of plasmidless Coxiella burnetii Scurry Q217. J Bacteriol 179, 3293-3297. (Pubitemid 27203005)
148. Willems, H., Jäger, C. & Baljer, G. (1998). Physical and genetic map of the obligate intracellular bacterium Coxiella burnetii. J Bacteriol 180, 3816-3822. (Pubitemid 28361576)
149. Williams, J. C., Peacock, M. G. & Mccaul, T. F. (1981). Immunological and biological characterization of Coxiella burnetii, phases I and II, separated from host components. Infect Immun 32, 840-851.
150. Williams, J. C., Hoover, T. A., Waag, D. M., Banerjeebhatnagar, N., Bolt, C. R. & Scott, G. H. (1990). Antigenic structure of Coxiella burnetii. A comparison of lipopolysaccharide and protein antigens as vaccines against Q fever. Ann N Y Acad Sci 590, 370-380.
151. Zamboni, D. S., McGrath, S., Rabinovitch, M. & Roy, C. R. (2003). Coxiella burnetii express type IV secretion system proteins that function similarly to components of the Legionella pneumophila Dot/ Icm system. Mol Microbiol 49, 965-976. (Pubitemid 36981342)
152. Zhang, G. & Samuel, J. E. (2003). Identification and cloning potentially protective antigens of Coxiella burnetii using sera from mice experimentally infected with Nine Mile phase I. Ann N Y Acad Sci 990, 510-520.
153. Zhang, Y. X., Zhi, N., Yu, S. R., Li, Q. J., Yu, G. Q. & Zhang, X. (1994). Protective immunity induced by 67-K outer-membrane protein of phase I Coxiella burnetii in mice and guinea pigs. Acta Virol 38, 327-332.
154. Zhang, G., Russell-Lodrigue, K. E., Andoh, M., Zhang, Y., Hendrix, L. R. & Samuel, J. E. (2007). Mechanisms of vaccine-induced protective immunity against Coxiella burnetii infection in BALB/c mice. J Immunol 179, 8372-8380.
155. Zuerner, R. L. & Thompson, H. A. (1983). Protein synthesis by intact Coxiella burnetii cells. J Bacteriol 156, 186-191.
156. Zusman, T., Yerushalmi, G. & Segal, G. (2003). Functional similarities between the icm/dot pathogenesis systems of Coxiella burnetii and Legionella pneumophila. Infect Immun 71, 3714-3723.